Related Experiment Video
Updated: May 30, 2025

Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19
Published on: May 25, 2022
Impact of COVID-19 on Ocular Surface Health: Infection Mechanisms, Immune Modulation, and Inflammatory Responses
Duliurui Huang1, Weixia Xuan2, Zhijie Li1,3
1Department of Ophthalmology, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou 450003, China.
Abstract:
COVID-19, caused by SARS-CoV-2, has presented formidable challenges to global health since its emergence in late 2019. While primarily known for respiratory symptoms, it can also affect the ocular surface. This review summarizes the effects of SARS-CoV-2 on ocular surface immunity and inflammation, focusing on infection mechanisms, immune responses, and clinical manifestations. Ocular symptoms, though uncommon, include conjunctivitis, dry eye, and blurred vision. SARS-CoV-2 binds to ACE2 receptors in ocular surface epithelial cells, facilitating viral entry, replication, and local dissemination. The innate immune responses involving corneal epithelial cells and immune cells are discussed, alongside mechanisms of antigen presentation and adaptive immunity. The review also examines the roles of cytokines and chemokines in mediating ocular surface inflammation and explores the impact of cytokine storms and chronic inflammation on ocular health. Additionally, the interplay between systemic and ocular immune responses is highlighted, analyzing how systemic COVID-19 inflammation influences ocular surface health. These insights underscore the broader implications of COVID-19 beyond localized ocular infection. By consolidating current findings, this review aims to guide preventive and therapeutic strategies while identifying directions for future research to mitigate the ocular consequences of COVID-19.
Insights
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can impact ocular surface immunity and inflammation, leading to symptoms like conjunctivitis. Understanding these effects is crucial for managing COVID-19
Area of Science:
- Ophthalmology
- Immunology
- Virology
Background:
- COVID-19, caused by SARS-CoV-2, primarily affects the respiratory system but also impacts the ocular surface.
- Ocular manifestations of COVID-19, though uncommon, include conjunctivitis, dry eye, and blurred vision.
Purpose of the Study:
- To review the effects of SARS-CoV-2 on ocular surface immunity and inflammation.
- To elucidate infection mechanisms, immune responses, and clinical manifestations related to ocular COVID-19.
Main Methods:
- Literature review summarizing current findings on SARS-CoV-2 and ocular health.
- Analysis of viral entry mechanisms, innate and adaptive immune responses, and inflammatory mediators.
Main Results:
- SARS-CoV-2 utilizes ACE2 receptors on ocular surface epithelial cells for entry and replication.
- Both innate and adaptive immune responses, involving cytokines and chemokines, contribute to ocular surface inflammation.
- Systemic COVID-19 inflammation can significantly influence ocular surface health.
Conclusions:
- COVID-19 poses risks to ocular surface immunity and inflammation beyond localized infection.
- Further research is needed to develop preventive and therapeutic strategies for ocular complications of COVID-19.
Related Concept Videos
Accessory Structures of the Eye
Glaucoma: Overview
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...

